Menu
GeneBe

rs751012696

Variant summary

Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM5PP3_Strong

The NM_001943.5(DSG2):c.889G>A(p.Asp297Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D297V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

DSG2
NM_001943.5 missense

Scores

7
9
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 9.02
Variant links:
Genes affected
DSG2 (HGNC:3049): (desmoglein 2) This gene encodes a member of the desmoglein family and cadherin cell adhesion molecule superfamily of proteins. Desmogleins are calcium-binding transmembrane glycoprotein components of desmosomes, cell-cell junctions between epithelial, myocardial, and other cell types. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This gene is present in a gene cluster with other desmoglein gene family members on chromosome 18. Mutations in this gene have been associated with arrhythmogenic right ventricular dysplasia, familial, 10. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 6 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr18-31524764-A-G is described in Lovd as [Likely_pathogenic].
PP3
MetaRNN computational evidence supports a deleterious effect, 0.991

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DSG2NM_001943.5 linkuse as main transcriptc.889G>A p.Asp297Asn missense_variant 8/15 ENST00000261590.13
DSG2XM_047437315.1 linkuse as main transcriptc.355G>A p.Asp119Asn missense_variant 9/16

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DSG2ENST00000261590.13 linkuse as main transcriptc.889G>A p.Asp297Asn missense_variant 8/151 NM_001943.5 P1
DSG2ENST00000682087.2 linkuse as main transcriptn.720G>A non_coding_transcript_exon_variant 6/6
DSG2ENST00000683614.2 linkuse as main transcriptn.720G>A non_coding_transcript_exon_variant 6/7

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152148
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000802
AC:
2
AN:
249388
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
135308
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000580
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000342
AC:
5
AN:
1461854
Hom.:
0
Cov.:
35
AF XY:
0.00000275
AC XY:
2
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000447
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152148
Hom.:
0
Cov.:
33
AF XY:
0.0000135
AC XY:
1
AN XY:
74300
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
ExAC
AF:
0.00000828
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Arrhythmogenic right ventricular cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthDec 18, 2023This missense variant replaces aspartic acid with asparagine at codon 297 of the DSG2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 20031616, 20857253). One of these individuals was homozygous for this variant (PMID: 20031616). This variant has been reported in an individual affected with arrhythmogenic cardiomyopathy (Carrillo-Aleman et al. 2019, doi: 10.1093/ehjci/jez110.005). Two relative carriers were also affected while another adult carrier was normal in the family. This variant has been identified in 3/280790 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthDec 20, 2022This missense variant replaces aspartic acid with asparagine at codon 297 of the DSG2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 20031616, 20857253). One of these individuals was homozygous for this variant (PMID: 20031616). This variant has been reported in an individual affected with arrhythmogenic cardiomyopathy (Carrillo-Aleman et al. 2019, doi: 10.1093/ehjci/jez110.005). Two relative carriers were also affected while another adult carrier was normal in the family. This variant has been identified in 3/280790 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Arrhythmogenic right ventricular dysplasia 10 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeDec 24, 2022This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 297 of the DSG2 protein (p.Asp297Asn). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DSG2 protein function. ClinVar contains an entry for this variant (Variation ID: 199804). This missense change has been observed in individual(s) with arrhythmogenic right ventriculardysplasia (ARVD) (PMID: 20031616, 20857253). This variant is present in population databases (rs751012696, gnomAD 0.006%). -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxApr 18, 2017The D297N variant in the DSG2 gene has been reported in association with ARVC (Bhuiyan et al., 2009; Tan et al., 2010). Bhuiyan et al. reported D297N as homozygous in a 36 year old male patient with ARVC. Also, one other patient diagnosed with ARVC was reported as heterozygous for the D297N variant but did not present with symptoms until after 50 years of age (Tan et al., 2010). Another variant at this same residue (D297G) and variants in nearby residues (K294E) have been reported in HGMD in association with ARVC (Stenson et al., 2014). Furthermore, D297N was not observed in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. However, Cox et al. reported the D297N substitution as an unclassified variant based on in silico predictors being inconsistent (Cox et al., 2011).In summary, while there have been at least two published reports indicating an association between the D297N variant and ARVC, additional evidence is needed to determine whether this variant is pathogenic or benign. -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 06, 2022The p.D297N variant (also known as c.889G>A), located in coding exon 8 of the DSG2 gene, results from a G to A substitution at nucleotide position 889. The aspartic acid at codon 297 is replaced by asparagine, an amino acid with highly similar properties. This alteration has been reported in individuals from arrhythmogenic right ventricular cardiomyopathy (ARVC) cohorts, including one homozygous case and one case with an additional PKP2 variant detected (Bhuiyan ZA et al. Circ Cardiovasc Genet, 2009 Oct;2:418-27; Tan BY et al. J Cardiovasc Transl Res, 2010 Dec;3:663-73; Cox MG et al. Circulation, 2011 Jun;123:2690-700). This variant has also been detected in a cardiomyopathy genetic testing cohort; however, clinical details were limited, and additional cardiac variants were detected (van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Benign
-0.035
T
BayesDel_noAF
Benign
-0.11
Cadd
Uncertain
25
Dann
Uncertain
1.0
DEOGEN2
Uncertain
0.64
D
Eigen
Pathogenic
0.72
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.87
D
M_CAP
Uncertain
0.24
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Uncertain
0.17
D
MutationAssessor
Pathogenic
4.0
H
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.60
T
PROVEAN
Pathogenic
-4.5
D
REVEL
Uncertain
0.55
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.024
D
Polyphen
1.0
D
Vest4
0.98
MutPred
0.98
Loss of sheet (P = 0.0817);
MVP
0.85
MPC
0.42
ClinPred
1.0
D
GERP RS
5.3
Varity_R
0.99
gMVP
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs751012696; hg19: chr18-29104726; API